Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer (Q59567546)
Jump to navigation
Jump to search
scientific article published on 25 November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer |
scientific article published on 25 November 2010 |
Statements
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer (English)
Guy Jerusalem
Angelica Fasolo
Veronique Dieras
Jonas Bergh
Luc Vittori
Yufen Zhang
Cristian Massacesi
25 November 2010